Formerly Happy Organon Employees Hate SGP and Are All Leaving ASAP! - Recensione dipendente - Global Drug Information Manager presso Merck

1,0
30 set 2008
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

It is a large company so very anonymous. You can get by here in a Wally-like" way and not be noticed for years if you do a minimum of work.

Svantaggi

Management elevated by the Peter Principle. They promote good workers who have no management skills rather than hire or create/train managers. Two faced management. They project that they are ethical and give us nothing but ethics/compliance training, yet lie about their clinical trials. They cut or force out good people to increase shareholder value. This is an awful place to work. Everyone who was knowledgeable from Organon has left.

Esplora altre recensioni su Merck

5,0
3 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

End of the year shutdown which includes paid time off

Svantaggi

The con for me at the time was that I had to relocate which wasn’t possible

4,0
2 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Over my tenure, I had the opportunity to work alongside highly talented and mission-driven colleagues dedicated to improving patient outcomes. The organization provided exposure to cross-functional collaboration, leadership development opportunities, and meaningful work supporting healthcare providers, patients, and community stakeholders. I appreciated the company's commitment to innovation, professional growth, and serving patients through scientific advancement.

Svantaggi

Like many large organizations, priorities and organizational structures evolved over time, which occasionally created uncertainty and changes in responsibilities. Decision-making processes could sometimes be complex due to the size of the organization, and navigating multiple layers of stakeholders occasionally impacted speed and execution.

Vedi recensioni per: Utile|Valutazione|Data|Tutto